Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
about
Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the MythsIs the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patientsInequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional studyMetabolic syndrome in antipsychotic naïve patients with schizophrenia: pooled analysis of data from three Indian studies.Is dietary pattern of schizophrenia patients different from healthy subjects?Theranostic Biomarkers for SchizophreniaIncentives and barriers to lifestyle interventions for people with severe mental illness: a narrative synthesis of quantitative, qualitative and mixed methods studies.The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia.A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment.Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit.Effects of high aerobic intensity training in patients with schizophrenia: a controlled trialNutrition and schizophrenia: an epidemiological and clinical perspective.Medical comorbidity in women and men with schizophrenia: a population-based controlled studyThe Metabolic Syndrome in Patients With Severe Mental IllnessesPhysical Health and Dual Diagnosis.Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.A review of clozapine safety.Body composition in patients with schizophrenia: Comparison with healthy controls.Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects.Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.Relationship between obesity and antipsychotic drug use in the adult population: a longitudinal, retrospective claim database study in Primary Care settingsCardiovascular effects of antipsychotics.An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia.Metabolic syndrome in people with schizophrenia: a review.Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients.Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: A preliminary studyA systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.The physical health of the seriously mentally ill: an overview of the literature.Nutritional therapy in practice for learning, behavioural and mood disorders.Lipid effects of psychiatric medications.The impact of weight gain associated with atypical antipsychotic use in schizophrenia.Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects.Incidence of diabetes in patients with schizophrenia: a population-based study.Psychotic disorder is an independent risk factor for increased fasting glucose and waist circumference.Potential role of amino acids in pathogenesis of schizophrenia.Obstructive sleep apnea: Underestimated risk factor in sudden cardiac death in schizophrenia.
P2860
Q24596954-A6052516-658F-415D-8D07-E3E8A7CA0C7EQ27027832-07A6B5D0-0735-4778-A0C2-60FA7722D99AQ28220276-88B91AEE-7050-4344-9FEB-527C4ED1FA49Q30736365-D1E6851E-4212-4942-B1A6-B351AB215523Q33283456-0E90830A-3FF6-4AD0-BA2F-7BE6E87F2918Q33624412-77B2A991-ECCE-4DB7-82F6-F001C7AF36D7Q33821289-CC6C028B-C00F-4D54-93DB-FF39D265EC95Q33968686-054F09E9-B86A-4E8A-A518-F13B6EB8C475Q34183522-6B1CE926-B5A6-4C03-8F22-121907A370FBQ34574728-FC62961E-C317-4955-83D8-86FDE3DFA6AAQ34786258-E6069676-300B-454B-9D4F-9A54A825EF28Q35202389-14B99FF8-D90F-4B4E-8145-6DB75259320DQ35619516-7C1A22E6-2098-4A4E-AA12-9375C5EB0441Q35696369-7A74A614-9CFE-43FA-B5D7-E608DC698341Q35884715-F3419D07-20F6-4F02-AD20-57CFD7E43901Q36009165-BAAAB01F-0927-4720-ADAE-65F61A2EA52EQ36040749-8F7B19EF-2E04-4A9D-976A-4511FCEA817EQ36178681-8482DEE2-DCF2-4A14-931C-29F365C3832EQ36191044-BD48D7A1-DB07-402B-A9E9-2FF7A7BDAE87Q36388181-25746EE3-1534-4555-94BB-D7F3730E5F09Q36568840-A193F8D0-02DD-475F-B0AA-DAB211FABBA8Q36744444-DE90D4E1-9824-4F01-B162-301FFB6D049EQ36823176-5A447CFF-8E29-4A99-844A-3F6004450220Q36836820-C4CF79EF-A97D-4726-850F-8E47454C2B27Q36870063-90BE7B5C-84D7-4780-A3B1-D246070BEA24Q37062558-509ACF0D-CD3D-4459-8B80-276D7884FEB3Q37129646-5C9E7730-D0D6-4CC3-BC11-B4F7D837F2AAQ37210118-454F8593-C0EB-4D1D-839C-7422E7EA5164Q37498113-7D806A97-8221-4D14-BE1F-500E102CA64EQ37798087-11AD224E-143E-4910-A822-6F366443E61CQ37954427-3E9C327C-F5A7-4EC7-A410-E0E6E8CDDEFDQ37964688-1C1B84C0-C5E8-42FF-BBB3-03E90EADDBBEQ38066118-FDCD251D-67A1-48E3-B1E1-A45AC6A9233EQ38777526-C66DB818-EF79-45DD-8292-1C45F0A1D2CAQ39610094-423FA7AD-30CD-48F4-8F83-062F3C338742Q39664112-0592FF52-6003-47DE-B421-D628D5B18F7AQ39971247-CBF127DB-B63C-4CBA-A8A0-52153E1AFF10Q40119718-9B5DDE88-D3DA-4B15-A0DE-55A2E599716BQ41706313-7EADC7B8-4EA5-4338-B8DB-3182343807E9Q42395447-A2861B53-C6E0-4500-AE09-3C71DAF4F277
P2860
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@ast
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@en
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@nl
type
label
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@ast
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@en
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@nl
prefLabel
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@ast
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@en
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@nl
P1433
P1476
Physical consequences of schizophrenia and its treatment: the metabolic syndrome.
@en
P2093
Jogin H Thakore
Martina C M Ryan
P304
P356
10.1016/S0024-3205(02)01646-6
P407
P577
2002-06-01T00:00:00Z